XML 96 R75.htm IDEA: XBRL DOCUMENT v3.23.1
Quarterly Financial Information (Unaudited) - Statements of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Mar. 31, 2022
Jun. 30, 2022
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:              
Net loss   $ (10,385) $ (15,553) $ (21,481) $ (25,412) $ (71,067) $ (51,853)
Adjustments to reconcile net loss to net cash used in operating activities:              
Noncash inventory reserve           5,323  
Depreciation   527 1,057 1,255 1,280 2,064 105
Amortization   61 124 188 254 159 171
Loss on disposition of assets $ 11,122     11,122 11,122    
Noncash stock-based compensation   764 1,433 1,969 2,493 3,338 2,818
Noncash amortization of deferred financing costs   419 797 1,635 1,969 1,661 1,341
Unrealized gain on warrants   (1,384) (8,435) (22,171) (25,520) (3,827)  
Changes in operating assets and liabilities:              
Accounts receivable   (132) (554) (2,178) (1,844) (668) (865)
Income taxes receivable   (4,675)          
Inventory   (1,727) (1,374) (831) (366) (6,289)  
Prepaid expenses and other assets   707 1,267 (1,551) 880 (967) (2,485)
Accounts payable and accrued expenses   1,095 3,643 (2,213) (628) 5,202 3,641
Lease liability   (21) (90) (132) (175) (131) (184)
Net cash used in operating activities   (14,751) (17,685) (34,388) (35,947) (65,202) (47,311)
Cash flows from investing activities:              
Purchases of marketable securities             (54,837)
Sales and maturities of marketable securities           39,729 14,500
Acquisition of property and equipment   (126) (133) (133) (133) (269) (353)
Net cash provided by investing activities   (126) (133) (133) (133) 39,460 (40,690)
Cash flows from financing activities:              
Proceeds from issuance of common stock in public offering, net of offering costs       21,971 21,936 21,081 48,434
Proceeds from Issuance of Long-term Debt             20,000
Repayments of long-term debt   (5,000) (5,000) (17,150) (17,375)    
Debt financing costs paid             (1,059)
Proceeds from exercise of stock options           75 610
Net cash provided by financing activities   (523) 11,702 21,523 22,183 30,422 67,985
Net (decrease) increase in cash and cash equivalents   (15,400) (6,116) (12,998) (13,897) 4,680 (20,016)
Cash and cash equivalents, beginning of period 13,027 19,143 19,143 19,143 19,143 14,463 34,479
Cash and cash equivalents, end of period 6,145 3,743 13,027 6,145 5,246 19,143 14,463
Supplemental cash flow information              
Interest paid   452 898 1,078 1,162 2,383 2,099
As Previously Reported | Error Correction, Accounting for Warrants              
Cash flows from operating activities:              
Net loss   (11,769) (23,988) (43,652)   (74,894)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Noncash inventory reserve           5,323  
Depreciation   527 1,057 1,255   2,064  
Amortization   61 124 188   159  
Loss on disposition of assets 11,122     11,122      
Noncash stock-based compensation   764 1,433 1,969   3,338  
Noncash amortization of deferred financing costs   419 797 1,635   1,661  
Changes in operating assets and liabilities:              
Accounts receivable   (132) (554) (2,178)   (668)  
Income taxes receivable   (4,675)          
Inventory   (1,727) (1,374) (831)   (6,289)  
Prepaid expenses and other assets   707 1,267 (1,551)   (967)  
Accounts payable and accrued expenses   1,095 3,643 (2,213)   5,202  
Lease liability   (21) (90) (132)   (131)  
Net cash used in operating activities   (14,751) (17,685) (34,388)   (65,202)  
Cash flows from investing activities:              
Sales and maturities of marketable securities           39,729  
Acquisition of property and equipment   (126) (133) (133)   (269)  
Net cash provided by investing activities   (126) (133) (133)   39,460  
Cash flows from financing activities:              
Proceeds from issuance of common stock in public offering, net of offering costs       21,971   21,081  
Repayments of long-term debt   (5,000) (5,000) (17,150)      
Proceeds from exercise of stock options           75  
Net cash provided by financing activities   (523) 11,702 21,523   30,422  
Net (decrease) increase in cash and cash equivalents   (15,400) (6,116) (12,998)   4,680  
Cash and cash equivalents, beginning of period 13,027 19,143 19,143 19,143 19,143 14,463  
Cash and cash equivalents, end of period $ 6,145 3,743 13,027 6,145   19,143 $ 14,463
Supplemental cash flow information              
Interest paid   452 898 1,078   2,383  
Error Correction, Adjustment | Error Correction, Accounting for Warrants              
Cash flows from operating activities:              
Net loss   1,384 8,435 22,171   3,827  
Adjustments to reconcile net loss to net cash used in operating activities:              
Unrealized gain on warrants   (1,384) (8,435) (22,171)   (3,827)  
Public offering              
Cash flows from financing activities:              
Proceeds from issuance of preferred stock in registered direct offering, net of offering costs   4,129 4,129 4,129 4,128    
Public offering | As Previously Reported | Error Correction, Accounting for Warrants              
Cash flows from financing activities:              
Proceeds from issuance of preferred stock in registered direct offering, net of offering costs   4,129 4,129 4,129      
At-the-market sales              
Cash flows from financing activities:              
Proceeds from At-the-Market sales of common stock, net of offering costs   348 12,573 12,573 $ 13,494 9,266  
At-the-market sales | As Previously Reported | Error Correction, Accounting for Warrants              
Cash flows from financing activities:              
Proceeds from At-the-Market sales of common stock, net of offering costs   $ 348 $ 12,573 $ 12,573   $ 9,266